+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Attention Deficit Hyperactivity Disorder"

South Africa Mental Health Market Overview, 2029 - Product Thumbnail Image

South Africa Mental Health Market Overview, 2029

  • Report
  • May 2024
  • 67 Pages
  • South Africa
From
Complete Mental Health Resource Guide, 2022/23 - Product Thumbnail Image

Complete Mental Health Resource Guide, 2022/23

  • Book
  • June 2022
  • 800 Pages
From
From
From
Developmental Psychopathology. Edition No. 1 - Product Thumbnail Image

Developmental Psychopathology. Edition No. 1

  • Book
  • July 2021
  • 480 Pages
Loading Indicator

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health disorder characterized by difficulty paying attention, hyperactivity, and impulsivity. It is most commonly diagnosed in children, but can persist into adulthood. Treatment for ADHD typically includes medication, psychotherapy, and lifestyle changes. The ADHD market is a subset of the larger mental health market, which is estimated to be worth billions of dollars. The ADHD market is expected to grow in the coming years due to increased awareness and diagnosis of the disorder. Several companies are involved in the ADHD market, including pharmaceutical companies that produce medications for the disorder, as well as companies that provide psychotherapy and lifestyle interventions. Examples of these companies include Shire, Novartis, and Otsuka Pharmaceuticals. Show Less Read more